Cargando…
Stratification of COVID-19 Severity Using SeptiCyte RAPID, a Novel Host Immune Response Test
SeptiCyte(®) RAPID is a gene expression assay measuring the relative expression levels of host response genes PLA2G7 and PLAC8, indicative of a dysregulated immune response during sepsis. As severe forms of COVID-19 may be considered viral sepsis, we evaluated SeptiCyte RAPID in a series of 94 patie...
Autores principales: | Gravrand, Victor, Mellot, François, Ackermann, Felix, Ballester, Marie-Christine, Zuber, Benjamin, Kirk, James T., Navalkar, Krupa, Yager, Thomas D., Petit, Fabien, Pascreau, Tiffany, Farfour, Eric, Vasse, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960895/ https://www.ncbi.nlm.nih.gov/pubmed/36851633 http://dx.doi.org/10.3390/v15020419 |
Ejemplares similares
-
Evaluation of the host immune response assay SeptiCyte RAPID for potential triage of COVID-19 patients
por: Montero, Maria Milagro, et al.
Publicado: (2023) -
2022. Modeling Improved Patient Management and Hospital Savings with SeptiCyte LAB in the Diagnosis of Sepsis at ICU Admission
por: Mchugh, Leo
Publicado: (2018) -
Erratum: Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU
Publicado: (2020) -
A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome
por: Pascreau, Tiffany, et al.
Publicado: (2021) -
Prognostic value of cellular population data in patients with COVID-19
por: Vasse, Marc, et al.
Publicado: (2023)